A newsletter from Oslo Teknopol covering activities in the life science cluster in the Oslo region.
Norwegian biotech is blossoming and sure to be in focus at BIO2010 in Chicago with a record number of companies attending. Read their profiles here.
Hamner Institute CEO Bill Greenlees reveals why Oslo Cancer Cluster is his European partner of choice for the new Global Biosciences Gateway launched at BIO2010.
Affitech signs Russian deal, Novo funds CP10 Pharma, Lien takes the helm at Biotec Pharmacon and HUNT links with Tissue Solutions in Business News.
Wireless medicine is the buzz word in Scandinavian medtech circles at the moment and has immense potential according to a new study.
Oncology 2020 is the theme for the second European Cancer Cluster Partnering Conference in Oslo 15-17 September 2010.
Providing a shot in the arm for vaccine development is the aim of one to watch Vaccibody and CEO Ole Henrik Brekke.